Haematopoietic stem cell transplant in a case of mucopolysaccharidosis IV with Fanconi anaemia and bone marrow failure.

BMJ Case RepSep 11, 2026 (epub)
Case ReportHematology

Swetlana Mukherjee, Garima Nirmal, Vaibhav Chadha et al.

✦ AI-curated · Sources linked

Case in brief

A child diagnosed with mucopolysaccharidosis type IV and Fanconi anaemia presented with bone marrow failure requiring haematopoietic stem cell transplantation. The patient underwent HSCT using a non-myeloablative conditioning regimen, which was tailored to optimize engraftment while minimizing toxicity. The case illustrates the successful management of these overlapping genetic disorders through careful planning and a multidisciplinary approach.

Diagnostic / clinical pearl

Clinicians should consider the complexities of managing patients with overlapping genetic conditions when planning haematopoietic stem cell transplantation, emphasizing the need for individualized treatment strategies.

Why it matters

This case underscores the importance of multidisciplinary collaboration in achieving favorable outcomes in patients with rare and complex genetic disorders requiring HSCT.

Source

Published in BMJ Case Rep. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Hematology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.